NLS Pharmaceutics Ltd. - Common Shares (NLSP) SEC filings
NLSP SEC filings moved a median of -1.05% by the close. NLSP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NLSP overview →
133 measured NLSP SEC filing events.
Where these NLSP SEC filings landedvs 127 measured NLSP SEC filing reactions
| Middle 50% of NLSP SEC filing reactions | -3.43% to +3.34% |
|---|---|
| Median reaction (to close) | -1.05% |
| Measured reactions | 127 |
Point-in-time · zero look-ahead
Half of the 127 NLSP SEC filing events with a measured close landed between -3.43% and +3.34%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT NewcelX Ltd. | SEC filing · Form EFFECT | — | — | |
| Form 6-K NewcelX Ltd. For: Nov 17 | SEC filing · Form 6-K | — | — | |
| Form 6-K NewcelX Ltd. For: Nov 07 | SEC filing · Form 6-K | — | — | |
| Form POS AM NewcelX Ltd. | SEC filing · Form POS | — | — | |
| Form 6-K NewcelX Ltd. For: Nov 04 | SEC filing · Form 6-K | — | — | |
| Form 6-K NewcelX Ltd. For: Nov 03 | SEC filing · Form 6-K | — | — | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 30 | SEC filing · Form 6-K | +1.94% | -1.05% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 29 | SEC filing · Form 6-K | -7.29% | -22.04% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 28 | SEC filing · Form 6-K | -7.29% | -22.04% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 27 | SEC filing · Form 6-K | +0.44% | -1.59% | |
| Form POS AM NLS Pharmaceutics Ltd. | SEC filing · Form POS | +0.44% | -1.59% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 23 | SEC filing · Form 6-K | -1.45% | -4.35% | |
| Form POS AM NLS Pharmaceutics Ltd. | SEC filing · Form POS | +0.00% | -0.59% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 09 | SEC filing · Form 6-K | -0.27% | -4.35% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 30 | SEC filing · Form 6-K | -1.60% | -2.04% | |
| Form EFFECT NLS Pharmaceutics Ltd. | SEC filing · Form EFFECT | +0.00% | +15.64% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 30 | SEC filing · Form 6-K | -6.69% | -18.30% | |
| Form F-1 NLS Pharmaceutics Ltd. | SEC filing · Form F-1 | -0.71% | -2.67% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 19 | SEC filing · Form 6-K | +0.00% | +7.28% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 10 | SEC filing · Form 6-K | +2.00% | +3.50% | |
| Form EFFECT NLS Pharmaceutics Ltd. | SEC filing · Form EFFECT | +2.00% | +3.50% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 04 | SEC filing · Form 6-K | -2.03% | +1.01% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | -2.03% | +1.01% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Aug 29 | SEC filing · Form 6-K | +0.95% | -1.91% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Aug 25 | SEC filing · Form 6-K | -0.89% | -4.46% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Aug 06 | SEC filing · Form 6-K | -0.13% | -0.53% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | +0.52% | +4.14% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jul 18 | SEC filing · Form 6-K | +0.45% | -0.45% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | +0.45% | -0.45% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jul 17 | SEC filing · Form 6-K | +0.24% | +0.90% | |
| Form D NLS Pharmaceutics Ltd. | SEC filing · Form D | +0.91% | -4.54% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jul 01 | SEC filing · Form 6-K | -1.70% | +9.83% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 30 | SEC filing · Form 6-K | -2.46% | +2.11% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | -0.22% | -2.15% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 16 | SEC filing · Form 6-K | +0.87% | -1.73% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 10 | SEC filing · Form 6-K | -2.29% | -2.67% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | -0.95% | +4.96% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 06 | SEC filing · Form 6-K | -0.95% | +4.96% | |
| Form 20-F NLS Pharmaceutics Ltd. For: Dec 31 | SEC filing · Form 20-F | +5.80% | +10.32% | |
| Form 6-K NLS Pharmaceutics Ltd. For: May 05 | SEC filing · Form 6-K | +0.00% | +3.59% | |
| Form NT 20-F NLS Pharmaceutics Ltd. For: Dec 31 | SEC filing · Form NT | +0.00% | +2.04% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Apr 24 | SEC filing · Form 6-K | — | +1.35% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Apr 15 | SEC filing · Form 6-K | -3.90% | -2.60% | |
| Form D NLS Pharmaceutics Ltd. | SEC filing · Form D | -3.90% | -2.60% | |
| Form 6-K/A NLS Pharmaceutics Ltd. For: Apr 04 | SEC filing · Form 6-K | +8.25% | +5.18% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 31 | SEC filing · Form 6-K | +12.77% | +9.22% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | -2.29% | +3.36% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 10 | SEC filing · Form 6-K | -1.70% | -3.96% | |
| Form F-4/A NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | +0.00% | -3.78% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Feb 27 | SEC filing · Form 6-K | -0.83% | +0.55% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Feb 25 | SEC filing · Form 6-K | -2.10% | -2.10% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Feb 10 | SEC filing · Form 6-K | +0.40% | +2.39% | |
| Form F-3 NLS Pharmaceutics Ltd. | SEC filing · Form F-3 | -2.17% | +1.74% | |
| Form F-3 NLS Pharmaceutics Ltd. | SEC filing · Form F-3 | +2.00% | -1.00% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 31 | SEC filing · Form 6-K | -6.27% | -17.82% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 30 | SEC filing · Form 6-K | +5.40% | +7.03% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 28 | SEC filing · Form 6-K | -3.83% | +2.73% | |
| Form D NLS Pharmaceutics Ltd. | SEC filing · Form D | +0.00% | -1.59% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 16 | SEC filing · Form 6-K | -0.01% | +3.03% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 14 | SEC filing · Form 6-K | +0.29% | -1.96% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 08 | SEC filing · Form 6-K | -8.81% | -1.23% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 07 | SEC filing · Form 6-K | -8.81% | -1.23% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 30 | SEC filing · Form 6-K | -7.45% | -3.55% | |
| Form F-4 NLS Pharmaceutics Ltd. | SEC filing · Form F-4 | -7.45% | -3.55% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 23 | SEC filing · Form 6-K | +0.00% | -1.38% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 19 | SEC filing · Form 6-K | +1.27% | +0.85% | |
| Form 6-K/A NLS Pharmaceutics Ltd. For: Dec 19 | SEC filing · Form 6-K | -3.91% | -12.56% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 17 | SEC filing · Form 6-K | +0.00% | +9.29% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 11 | SEC filing · Form 6-K | -2.66% | +6.92% | |
| Form 6-K/A NLS Pharmaceutics Ltd. For: Dec 10 | SEC filing · Form 6-K | -0.50% | -1.00% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 04 | SEC filing · Form 6-K | +2.51% | -5.86% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 03 | SEC filing · Form 6-K | -6.56% | -11.80% | |
| Form EFFECT NLS Pharmaceutics Ltd. | SEC filing · Form EFFECT | +0.00% | -8.66% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 18 | SEC filing · Form 6-K | +0.00% | +0.93% | |
| Form F-3/A NLS Pharmaceutics Ltd. | SEC filing · Form F-3 | — | +0.00% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 15 | SEC filing · Form 6-K | +0.00% | +0.93% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 12 | SEC filing · Form 6-K | +0.64% | +9.84% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 08 | SEC filing · Form 6-K | +0.00% | +4.75% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 06 | SEC filing · Form 6-K | +0.00% | +4.53% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 05 | SEC filing · Form 6-K | -2.41% | -2.65% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 04 | SEC filing · Form 6-K | -6.33% | -7.38% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 28 | SEC filing · Form 6-K | — | -2.38% | |
| Form F-3 NLS Pharmaceutics Ltd. | SEC filing · Form F-3 | -1.76% | -6.37% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 22 | SEC filing · Form 6-K | +0.00% | -2.02% | |
| Form D NLS Pharmaceutics Ltd. | SEC filing · Form D | — | -1.83% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 30 | SEC filing · Form 6-K | +1.35% | -8.46% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 15 | SEC filing · Form 6-K | +0.00% | +5.53% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 11 | SEC filing · Form 6-K | -1.10% | -2.20% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 10 | SEC filing · Form 6-K | -1.10% | -2.20% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 07 | SEC filing · Form 6-K | — | +5.39% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 01 | SEC filing · Form 6-K | +0.00% | -4.23% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 25 | SEC filing · Form 6-K | +0.00% | -4.13% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 19 | SEC filing · Form 6-K | -5.59% | +4.14% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 16 | SEC filing · Form 6-K | +0.00% | +7.80% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Sep 13 | SEC filing · Form 6-K | -2.00% | -6.21% | |
| Form F-1 NLS Pharmaceutics Ltd. | SEC filing · Form F-1 | -0.41% | -9.03% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Aug 26 | SEC filing · Form 6-K | — | -2.42% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Aug 15 | SEC filing · Form 6-K | +3.79% | +4.20% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Aug 14 | SEC filing · Form 6-K | +2.04% | -2.95% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jul 30 | SEC filing · Form 6-K | -2.56% | -4.61% | |
| Form D NLS Pharmaceutics Ltd. | SEC filing · Form D | +1.10% | +7.33% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jul 01 | SEC filing · Form 6-K | +0.05% | +3.32% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 27 | SEC filing · Form 6-K | -6.19% | +1.74% | |
| Form EFFECT NLS Pharmaceutics Ltd. | SEC filing · Form EFFECT | +0.98% | +11.82% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 25 | SEC filing · Form 6-K | -4.03% | -0.27% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 11 | SEC filing · Form 6-K | -2.26% | -6.32% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 06 | SEC filing · Form 6-K | +1.22% | -2.67% | |
| Form 6-K NLS Pharmaceutics Ltd. For: May 31 | SEC filing · Form 6-K | +1.94% | -2.37% | |
| Form F-1 NLS Pharmaceutics Ltd. | SEC filing · Form F-1 | +0.64% | -3.88% | |
| Form 6-K NLS Pharmaceutics Ltd. For: May 28 | SEC filing · Form 6-K | +3.33% | +0.23% | |
| Form 6-K NLS Pharmaceutics Ltd. For: May 24 | SEC filing · Form 6-K | +3.33% | +0.23% | |
| Form 6-K NLS Pharmaceutics Ltd. For: May 22 | SEC filing · Form 6-K | +0.00% | +1.07% | |
| Form 20-F NLS Pharmaceutics Ltd. For: Dec 31 | SEC filing · Form 20-F | -0.44% | +9.37% | |
| Form 6-K NLS Pharmaceutics Ltd. For: May 14 | SEC filing · Form 6-K | -0.73% | -3.31% | |
| Form NT 20-F NLS Pharmaceutics Ltd. For: Dec 31 | SEC filing · Form NT | +0.00% | +2.21% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Apr 19 | SEC filing · Form 6-K | +1.89% | -1.96% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Apr 15 | SEC filing · Form 6-K | — | -2.14% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Apr 08 | SEC filing · Form 6-K | +1.00% | +1.29% | |
| Form D NLS Pharmaceutics Ltd. | SEC filing · Form D | +0.94% | -3.63% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 21 | SEC filing · Form 6-K | -7.19% | +7.78% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 19 | SEC filing · Form 6-K | +0.00% | -45.86% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 20 | SEC filing · Form 6-K | +0.00% | -45.86% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 13 | SEC filing · Form 6-K | — | -4.31% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Mar 11 | SEC filing · Form 6-K | +0.00% | -10.79% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Feb 23 | SEC filing · Form 6-K | +0.00% | +3.80% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jan 12 | SEC filing · Form 6-K | +0.00% | -0.68% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 29 | SEC filing · Form 6-K | -6.50% | -2.02% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 22 | SEC filing · Form 6-K | +0.00% | +6.81% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Jun 30 | SEC filing · Form 6-K | +11.91% | +0.37% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 04 | SEC filing · Form 6-K | +4.00% | +10.10% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Dec 01 | SEC filing · Form 6-K | +9.52% | -3.17% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Nov 16 | SEC filing · Form 6-K | +3.13% | +9.38% | |
| Form 6-K NLS Pharmaceutics Ltd. For: Oct 25 | SEC filing · Form 6-K | +0.00% | -5.46% |
Keep exploring
More NLSP: earnings → · analyst actions → · NLSP overview →